Kelly C. Rogers, Pharm.D., FCCP

Department of Clinical Pharmacy

Tel: (901) 448-3702


  • None, University of Virginia Health Sciences Center, Charlottesville, VA, PGY-1 Residency
  • Pharm.D., University of TN COP, Memphis, Pharmacy
  • None, University of Memphis, Memphis, Pre-Pharmacy


  1. Finks, SW, Airee, A, Chow, SL, Macaulay, TE, Moranville, MP, Rogers, KC, Trujillo, TC. Key articles of dietary interventions that influence cardiovascular mortality. Pharmacotherapy, 32 (4), e54-87, 2012.
  2. Rogers KC, Wallace JP, Foster SL, Finks SW. Annual Influenza Vaccination: Offering Protection Beyond Infection.. So Med J, 7 (105), 379-386, 2012.
  3. Rogers KC, Faircloth JM, Finks SW.. The Use of Cilostazol in Percutaneous Coronary Intervention.. Ann Pharmacother, 46, 839-50, 2012.
  4. Finks, SW, Rogers, KC, Manguso, AH. Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement. Int J Pharm Pract, 19 (4), 281-6, 2011.
  5. Goddard, KB, Eppert, HD, Underwood, EL, McLean, KM, Finks, SW, Rogers, KC. Basic life support and cardiopulmonary resuscitation training for pharmacy students and the community by a pharmacy student committee. Am J Pharm Educ, 74 (6), 100, 2010.
  6. Finks, SW, Oliphant, CS, Manguso, AH, Rogers, KC, Bridges, G, Haidar, CE, Lee, KR, Lee, M, Lobo, B, May, AM, Reaves, A, Swanson, JM, Swims, M, Vinson, J, Yates, ME. Activities of Memphis-area hospitals to meet National Patient Safety Goals for warfarin therapy. Am J Health Syst Pharm, 66 (24), 2179-88, 2009.
  7. Rogers, KC, Finks, SW. Job sharing for women pharmacists in academia. Am J Pharm Educ, 73 (7), 135, 2009.
  8. Czosnowski, QA, Finks, SW, Rogers, KC. Bivalirudin for patients with heparin-induced thrombocytopenia undergoing cardiovascular surgery. Ann Pharmacother, 42 (9), 1304-9, 2008.
  9. Finks, SW, Rogers, KC. Job-sharing. Drs. Finks and Rogers interviewed by Kate Traynor, M.S., AJHP News writer. Am J Health Syst Pharm, 65 (1), 69-72, 2008.
  10. Rogers, KC, Wolfe, DA. Ibutilide: a class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter. J Emerg Med, 20 (1), 67-71, 2001.
  11. Rogers, KC, Wolfe, DA. Amiodarone-induced blue-gray syndrome. Ann Pharmacother, 34 (9), 1075, 2000.